TABLE 2.
Mutation rate of A/Swine/Germany/2/81
| Clone no. | Plaque inhibition assay result (PFU/ml)
|
Allantoic fluid (ml) | Population size (PFU)a | Mutant frequencyb | Mutation rate (bp/site/replication)c | Quotient (control/ amantadine) | Quotient × 4 | Quotient × 4/ genome length | |
|---|---|---|---|---|---|---|---|---|---|
| Control | Amantadine | ||||||||
| 1 | 9.2 × 108 | 1.2 × 105 | 13.0 | 1.2 × 1010 | 1.3 × 10−4 | 1.9 × 10−6 | 7.7 × 103 | 3.1 × 104 | 2.3 |
| 2 | 6.0 × 108 | 2.6 × 105 | 9.0 | 5.4 × 109 | 4.3 × 10−4 | 6.7 × 10−6 | 2.3 × 103 | 9.2 × 103 | 0.7 |
| 3 | 2.3 × 108 | 1.8 × 105 | 13.0 | 3.0 × 109 | 7.8 × 10−4 | 1.2 × 10−5 | 1.3 × 103 | 5.1 × 103 | 0.4 |
| 4 | 6.0 × 108 | 2.6 × 105 | 11.0 | 6.6 × 109 | 4.3 × 10−4 | 6.6 × 10−6 | 2.3 × 103 | 9.2 × 103 | 0.7 |
| 5 | 1.0 × 109 | 2.0 × 105 | 12.0 | 1.2 × 1010 | 2.0 × 10−4 | 3.0 × 10−6 | 5.0 × 103 | 2.0 × 104 | 1.5 |
| 6 | 2.2 × 108 | 8.0 × 104 | 10.7 | 2.4 × 109 | 3.6 × 10−4 | 5.8 × 10−6 | 2.8 × 103 | 1.1 × 104 | 0.8 |
| 7 | 4.2 × 108 | 1.4 × 105 | 9.3 | 3.9 × 109 | 3.3 × 10−4 | 5.2 × 10−6 | 3.0 × 103 | 1.2 × 104 | 0.9 |
| 8 | 4.0 × 107 | 4.0 × 104 | 8.6 | 3.4 × 108 | 1.0 × 10−3 | 1.8 × 10−5 | 1.0 × 103 | 4.0 × 103 | 0.3 |
| 9 | 6.0 × 107 | 1.8 × 104 | 9.6 | 5.8 × 108 | 3.0 × 10−4 | 5.2 × 10−6 | 3.3 × 103 | 1.3 × 104 | 1.0 |
| 10 | 3.2 × 107 | 2.0 × 104 | 10.5 | 3.4 × 108 | 6.3 × 10−4 | 1.1 × 10−5 | 1.6 × 103 | 6.4 × 103 | 0.5 |
| 11 | 1.0 × 108 | 1.2 × 104 | 6.0 | 6.0 × 108 | 1.2 × 104 | 2.1 × 10−6 | 8.3 × 103 | 3.3 × 104 | 2.5 |
| 12 | 4.0 × 108 | 4.0 × 104 | 13.5 | 5.4 × 109 | 1.0 × 10−4 | 1.5 × 10−6 | 1.0 × 104 | 4.0 × 104 | 2.9 |
| 13 | 2.8 × 108 | 2.4 × 105 | 10.8 | 3.0 × 109 | 8.6 × 10−4 | 1.4 × 10−5 | 1.2 × 103 | 4.7 × 103 | 0.3 |
| 14 | 4.0 × 107 | 8.0 × 103 | 8.8 | 3.5 × 108 | 2.0 × 10−4 | 3.5 × 10−6 | 5.0 × 103 | 2.0 × 104 | 1.5 |
| 15 | 1.2 × 108 | 4.8 × 104 | 9.0 | 1.1 × 109 | 4.0 × 10−4 | 6.7 × 10−6 | 2.5 × 103 | 1.0 × 104 | 0.7 |
| 16 | 1.3 × 108 | 1.6 × 104 | 11.9 | 1.5 × 109 | 1.2 × 10−4 | 2.0 × 10−6 | 8.1 × 103 | 3.3 × 104 | 2.4 |
| 17 | 1.4 × 108 | 9.6 × 104 | 9.8 | 1.4 × 109 | 6.9 × 10−4 | 1.1 × 10−5 | 1.5 × 103 | 5.8 × 103 | 0.4 |
| Average | 3.1 × 108 | 1.0 × 105 | 3.5 × 109 | 4.2 × 10−4 | 6.8 × 10−6 | 3.9 × 103 | 1.6 × 104 | 1.2 | |
Product of titer from control and amount of allantoic fluid.
Quotient of titers from plaque inhibition assays with amantadine and control.
Rate for each clone calculated from mutant frequency and population size as described in Materials and Methods.